Ameriprise Financial Inc Xencor Inc Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Xencor Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 292,576 shares of XNCR stock, worth $4.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

292,576

Previous 169,706 72.4%

Holding current value

$4.61 Million

Previous $3.41 Million 97.04%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$19.43 - $26.84 $2.39 Million - $3.3 Million	122,870 Added 72.4%	292,576 $6.72 Million
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $350,659 - $483,552	-22,335 Reduced 11.63%	169,706 $3.41 Million
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $688,975 - $926,957	-37,835 Reduced 16.46%	192,041 $3.64 Million
Q1 2024 May 15, 2024	SELL	$18.65 - $26.52 $456,440 - $649,050	-24,474 Reduced 9.62%	229,876 $5.09 Million
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $1.6 Million - $2.08 Million	-96,916 Reduced 27.59%	254,350 $5.4 Million
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $558,123 - $705,715	-27,795 Reduced 7.33%	351,266 $7.08 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $200,215 - $241,681	-8,083 Reduced 2.09%	379,061 $9.47 Million
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $184,037 - $262,049	-7,092 Reduced 1.8%	387,144 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $490,296 - $610,349	19,778 Added 5.28%	394,236 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $2.24 Million - $2.95 Million	91,021 Added 32.11%	374,458 $9.73 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $182,910 - $268,806	9,266 Added 3.38%	283,437 $7.76 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $230,061 - $358,975	8,623 Added 3.25%	274,171 $7.32 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $107,171 - $138,269	3,183 Added 1.21%	265,548 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $215,285 - $250,616	-7,024 Reduced 2.61%	262,365 $8.57 Million
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $579,112 - $753,706	-16,869 Reduced 5.89%	269,389 $9.29 Million
Q1 2021 May 17, 2021	SELL	$40.81 - $53.88 $178,951 - $236,263	-4,385 Reduced 1.51%	286,258 $12.3 Million
Q4 2020 Feb 12, 2021	SELL	$36.63 - $47.63 $1.02 Million - $1.33 Million	-27,958 Reduced 8.78%	290,643 $12.7 Million
Q3 2020 Nov 16, 2020	BUY	$30.09 - $43.02 $733,714 - $1.05 Million	24,384 Added 8.29%	318,601 $12.4 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $1.04 Million - $1.25 Million	37,352 Added 14.54%	294,217 $9.53 Million
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $6,724 - $12,281	325 Added 0.13%	256,865 $7.67 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $253,648 - $320,875	-7,745 Reduced 2.93%	256,540 $8.82 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $8.91 Million - $12.2 Million	264,285 New	264,285 $8.92 Million

Others Institutions Holding XNCR

# of Institutions

199

Shares Held

73.7M

Call Options Held

1.7K

Put Options Held

4.2K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $940M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Xencor Inc Transaction History